Literature DB >> 2060086

Assessment of chemotherapy-associated nephrotoxicity in children with cancer.

R Skinner1, A D Pearson, M G Coulthard, A W Skillen, A W Hodson, M E Goldfinch, I Gibb, A W Craft.   

Abstract

Assessment of the toxicity caused by chemotherapy in children with cancer has become more important as the number of long-term survivors has continued to increase. It is vital to monitor both acute life-threatening adverse effects and long-term toxicity that may impair the child's development and cause permanent morbidity. Renal damage may follow treatment with cytotoxic drugs, especially cisplatin or ifosfamide, and lead to glomerular, proximal tubular or distal tubular impairment or to any combination of these. Greater understanding of nephrotoxicity and of its prevention may enable the use of more intensive schedules or of higher doses of potentially nephrotoxic chemotherapy. However, the evaluation of cytotoxic drug-induced nephrotoxicity has frequently depended mainly on measurement of the plasma creatinine concentration, which may remain normal despite substantial glomerular impairment or severe tubular dysfunction. Detailed assessment of nephrotoxicity depends on an understanding of normal renal physiology and requires evaluation of all aspects of function. A comprehensive but simple investigatory protocol that enables assessment of the nature and severity of nephrotoxicity in children is described, which can be performed without admission to hospital. Glomerular function is assessed by measurement of the glomerular filtration rate from the plasma clearance of [51Cr]-ethylenediaminetetraacetic acid ([51Cr]-EDTA). Proximal nephron function is evaluated in three ways: by measurement of the concentration of calcium, magnesium, phosphate, glucose and urate in blood and urine along with calculations of their fractional excretion and of the renal threshold for phosphate; by determination of the excretion in urine of low-molecular-weight proteins (e.g. retinol-binding protein); and by investigation of urinary bicarbonate excretion in patients who are acidotic. Distal nephron function is initially investigated by examination of the concentration (osmolality) and acidification (pH) of an early morning sample of urine. Finally, a group of general investigations is performed, including quantitation of urinary excretion of renal tubular enzymes (e.g. N-acetylglucosaminidase) and measurement of blood pressure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2060086     DOI: 10.1007/bf00689694

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  65 in total

1.  Hypophosphataemic rickets after ifosfamide treatment in children.

Authors:  R Skinner; A D Pearson; L Price; K Cunningham; A W Craft
Journal:  BMJ       Date:  1989-06-10

2.  Measurement of blood pressure in children. Recommendations of a working party of the British Hypertension Society.

Authors:  M de Swiet; M J Dillon; W Littler; E O'Brien; P L Padfield; J C Petrie
Journal:  BMJ       Date:  1989-08-19

3.  Centralisation of treatment and survival rates for cancer.

Authors:  C A Stiller
Journal:  Arch Dis Child       Date:  1988-01       Impact factor: 3.791

4.  Chronic renal failure in children treated with methyl CCNU.

Authors:  W E Harmon; H J Cohen; E E Schneeberger; W E Grupe
Journal:  N Engl J Med       Date:  1979-05-24       Impact factor: 91.245

Review 5.  Beta 2-microglobulin: its significance in the evaluation of renal function.

Authors:  G H Schardijn; L W Statius van Eps
Journal:  Kidney Int       Date:  1987-11       Impact factor: 10.612

6.  Evaluation of renal function in malnutrition.

Authors:  S Klahr; K Tripathy
Journal:  Arch Intern Med       Date:  1966-10

7.  Renal bicarbonate reabsorption and hydrogen ion excretion in normal infants.

Authors:  C M Edelmann; J R Soriano; H Boichis; A B Gruskin; M I Acosta
Journal:  J Clin Invest       Date:  1967-08       Impact factor: 14.808

Review 8.  Three decades of chemotherapy for childhood cancer: from cure 'at any cost' to cure 'at least cost'.

Authors:  A W Craft; A D Pearson
Journal:  Cancer Surv       Date:  1989

9.  Cis-platinum-induced renal sodium wasting.

Authors:  P J Lammers; L White; L J Ettinger
Journal:  Med Pediatr Oncol       Date:  1984

10.  Ifosfamide-induced subclinical tubular nephrotoxicity despite mesna.

Authors:  M P Goren; R K Wright; M E Horowitz; C B Pratt
Journal:  Cancer Treat Rep       Date:  1987-02
View more
  18 in total

Review 1.  Renal toxicity and chemotherapy in children with cancer.

Authors:  Antonio Ruggiero; Pietro Ferrara; Giorgio Attinà; Daniela Rizzo; Riccardo Riccardi
Journal:  Br J Clin Pharmacol       Date:  2017-09-20       Impact factor: 4.335

2.  Renal function following unilateral nephrectomy for neuroblastoma and Wilms' tumour.

Authors:  M Schell; P Cochat; A Hadj-Aïssa; E Bouffet; L Dubourg; M Brunat-Mentigny
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

Review 3.  Cytostatics--induced tubular toxicity.

Authors:  M Brandis; K von der Hardt; R B Zimmerhackl; M Mohrmann; J Leititis
Journal:  Clin Investig       Date:  1993-10

4.  Renal dysfunction and elevated blood pressure in long-term childhood cancer survivors.

Authors:  Sebastiaan L Knijnenburg; Monique W Jaspers; Helena J van der Pal; Antoinette Y Schouten-van Meeteren; Antonia H Bouts; Jan A Lieverst; Arend Bökenkamp; Caro C E Koning; Foppe Oldenburger; James C H Wilde; Flora E van Leeuwen; Huib N Caron; Leontien C Kremer
Journal:  Clin J Am Soc Nephrol       Date:  2012-07-19       Impact factor: 8.237

5.  Cell death-inducing effect of novel palladium(II) and platinum(II) complexes on non-small cell lung cancer cells in vitro.

Authors:  Engin Ulukaya; Ferda Ari; Konstantinos Dimas; Mehmet Sarimahmut; Emel Guney; Nikos Sakellaridis; Veysel T Yilmaz
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-02       Impact factor: 4.553

6.  Inaccuracy of glomerular filtration rate estimation from height/plasma creatinine ratio.

Authors:  R Skinner; M Cole; A D Pearson; M J Keir; L Price; R A Wyllie; M G Coulthard; A W Craft
Journal:  Arch Dis Child       Date:  1994-05       Impact factor: 3.791

7.  The influence of age on nephrotoxicity following chemotherapy in children.

Authors:  R Skinner; A D Pearson; L Price; M G Coulthard; A W Craft
Journal:  Br J Cancer Suppl       Date:  1992-08

8.  Technetium-99m dimercaptosuccinic acid and ifosfamide tubular dysfunction in children with cancer.

Authors:  J K Anninga; R A Valdés Olmos; J de Kraker; H van Tinteren; C A Hoefnagel; E A van Royen
Journal:  Eur J Nucl Med       Date:  1994-07

Review 9.  Anticancer drug-induced kidney disorders.

Authors:  P E Kintzel
Journal:  Drug Saf       Date:  2001-01       Impact factor: 5.228

10.  Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.

Authors:  Esmee Cm Kooijmans; Arend Bökenkamp; Nic S Tjahjadi; Jesse M Tettero; Eline van Dulmen-den Broeder; Helena Jh van der Pal; Margreet A Veening
Journal:  Cochrane Database Syst Rev       Date:  2019-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.